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Introduction
In respect of the fossil fuel energy crisis and environ-
mental protection, cycling for leisure or transport is
popular in Taiwan. Without sudden impact during exer-
cise, light to moderate aerobic cycling is a healthy alter-
native exercise for the elderly to avoid injury to the foot
or ankle. It has been reported that people who cycle to
work 3 hours per week can decrease the risk of mortality
by up to 40% when compared with non-participants1.
In elderly subjects with habitual 15–29 minutes of walk-
ing or cycling to work in Finland, a marked decrease in
cardiovascular mortality was observed2.
Regular, moderate exercise for 60 minutes per week
for 12 months in the elderly was found to enhance
mucosal immune function, and both the concentration
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SUMMARY
Background: Whether middle-aged people with habitual cycling exercise (HCE) at low intensity in the morning
have higher immunity against hepatitis B virus than sedentary controls (SCs) is a health issue in the elderly.
Methods: Conditioned media (CM) were prepared by stimulating isolated human peripheral blood mononu-
clear cells (MNC) with phytohemagglutinin (PHA) or assessment of their inhibitory effects on hepatitis B surface
antigen expression in human hepatoma Hep3B cells.
Results: With the percent of maximal oxygen uptake at about 45.52% and percent of maximal heart rate at about
68.58% during a cycling exercise program in the present study, we considered HCE as an aerobic and a low to mod-
erate exercise for the elderly. The concentrations of secreted cytokines such as interferon gamma, tumor necro-
sis factor α and interferon alpha were higher in the MNC-CM from the HCE group than from the SC group. The
inhibitory rates of MNC-CM of the HCE group against hepatitis B surface antigen expression were higher than
that of the SC group. In the same stimulating concentration of PHA (10 μg/mL), the relative hepatitis B surface anti-
gen expression in MNC-CM of the HCE group was 64.7% versus 81.5% of the SC group. The reduction in inhibitory
rates in cytokine neutralization experiments suggests crucial roles of these cytokines for the inhibitory effect of
HCE-PHA-MNC-CM against hepatitis B surface antigen expression.
Conclusion: The results reveal that the immune response of MNC, which are stimulated by PHA to suppress hep-
atitis B surface antigen expression, is greater in middle-aged subjects with low-speed HCE than in sedentary
subjects. [International Journal of Gerontology 2010; 4(2): 82–88]
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and secretory rate of IgA in salivary were increased3. It is
well known that exercise can modulate immune func-
tion, depending on the intensity of exercise4. Some
studies have mentioned the effect of exercise on cellu-
lar immune function in the elderly5–8. For example,
habitual elderly endurance exercisers had a greater T-
cell function than sedentary controls (SCs) in a cross-
sectional survey9. Furthermore, elderly women with
16 weeks of endurance training developed greater rest-
ing natural killer cell activity compared with SCs10.
After moderate exercise intervention, elderly sub-
jects being administered a trivalent influenza vaccine
had reduced antibody titer in their blood compared
with controls11. The greater resistance in mice against
infection by herpes simplex virus type 1 was also as-
sumed to be related to moderate exercise12.
There are some cytokines associated with immunity
against viruses. Interferon gamma (IFN-γ) secreted by
human peripheral blood mononuclear cells (PBMNC),
was observed to exhibit a marked inhibitory effect on
hepatitis B virus (HBV) expression without cytolytic
effects in cells13. There was some evidence that tumor
necrosis factor α (TNF-α) may also be involved in the
activation of the cell-mediated antiviral immune re-
sponse to HBV. The cell-mediated antiviral immune
response to HBV in PBMNC in children may be attrib-
uted to higher TNF-α production14. Exercise can aug-
ment the secretion of TNF-α in the plasma of healthy
men after moderate exercise15.
We proposed that regular aerobic cycling exercise
will improve the immune response of phytohemagglu-
tinin (PHA) against HBV expression in human hepatoma
Hep3B cells. To evaluate the difference in immune re-
sponse against HBV expression between middle-aged
people performing habitual cycling exercise (HCE) and
(SCs), we isolated PBMNC and incubated them with
PHA to simulate the immune reaction induced in vivo.
Whether any antiviral effect was induced by the secre-
tion of cytokines from PBMNC was also assessed.
Subjects and Methods
Subjects
The human ethics committee of Chinese Culture Uni-
versity authorized the study. Fifteen middle-aged males
were recruited and gave their informed consent. Those
with HCE lasting 2 hours in the morning at least twice
a week for more than 2 years were recruited as the HCE
group. Another 14 males with no participation in any
other habitual physical activities before the study were
recruited as the SC group. All subjects were examined by
a clinic physician and were judged to have no clinical his-
tory of obvious musculoskeletal illness, pulmonary dis-
ease and cardiovascular disease, and were neither HBV
carriers nor hepatitis B surface antigen (HBsAg)-positive.
Furthermore, they had not had any other surgical treat-
ment during the 4 months prior to blood collection and
the experimental period. Before blood collection, the
HCE group underwent a HCE program for 2 months. The
HCE program was cycling exercise at a speed equiva-
lent to a percent peak oxygen uptake (V· O2peak) of 32%
from 5:00 to 8:00 in the morning twice a week. Other
physical activities were prohibited during the experi-
mental period. All subjects had breakfast, including
three slices of white toast, one egg and 240 mL of milk,
30 minutes before the HCE program. Intake of any caf-
feinated beverages, alcoholic drinks or drugs, smoking,
and a vegetarian diet were restricted for 4 weeks before
the study, as well as during the experimental period. To
ensure the same intensity of exercise in each subject, a
heart rate meter (pacer heart rate monitor; Polar, Port
Washington, NY, USA) was worn during all the HCE to
help maintain the heart rate at a constant rate. Blood
samples, before eating and after the subjects had rested
quietly for at least 48 hours, were taken between 8:00
and 9:00 in the morning. All subjects of the HCE and SC
groups, who had a mean age of 67.0 ± 5.6 years (range,
59–69 years), mean height of 164.2 ± 8.3 cm and mean
weight of about 62.1 ± 9.5 kg, were volunteers. The
baseline anthropometric data between the HCE and SC
groups showed no significant differences (Table 1).
Measurements of cardiopulmonary fitness
Two visits were required by each subject in the prelim-
inary study. The first visit was the measurement of
V· O2peak and oxygen consumption. The second visit was
to determine the cycling speed with a 32% V· O2peak dur-
ing the HCE. The V· O2peak and oxygen consumption were
measured by a respiratory monitoring system (MetaMax
3B; Cortex Biophysik GmbH, Leipzig, Germany), while the
subjects were riding an electronically braked cycle ergom-
eter (Corival 400; Lode, Groningen, The Netherlands) with
incremental exercise testing. The test for the V· O2peak
was completed 1 month before the experimental period.
After warming up with preliminary exercise at 75 W for
2 minutes, the subjects had increased loading at 25 W
every 2 minutes until volitional fatigue.
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Hepatoma cell cultures
We used Hep3B/C16 (Hep3B) cell cultures, which are a
human hepatocellular carcinoma cell line with the HBV
genome integrated into its chromosome giving stable
production of HBsAg, as the cell model for studying
HBV replication16,17.
We found that about 30% by volume of mononu-
clear cell (MNC) conditioned medium (CM) was suit-
able for Hep3B cells in our preliminary experimental
work. The MNC-CM was added into fresh Dulbecco’s
modified Eagle’s medium (Invitrogen, Carlsbad, CA,
USA) with 10% fetal calf serum for incubation of
Hep3B cells for 3 days at 37°C in a humidified 5% CO2
incubator. The Hep3B cells were incubated in Dulbecco’s
modified Eagle’s medium, containing 10% fetal calf
serum (Invitrogen), streptomycin at 100 mg/L, L-gluta-
mine at 1,000 μmol/L, and penicillin at 105 IU/L, in a
humidified 5% CO2 incubator at 37°C at an initial con-
centration of 1×106 cells/mL. There was no direct effect
on the relative HBsAg expression and on the viability
of Hep3B cells by a PHA concentration of 10 μg/ mL in
the MNC-CM. We used the tetrazolium dye MTT [(3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide)] colorimetric test to evaluate cell viability18.
Hep3B cell medium, which was incubated with 30%
phosphate-buffered saline containing PHA at 10μg/mL,
replaced the MNC-CM and represented the untreated
control group. Cell viability was calculated by dividing
the MTT value of Hep3B treated with MNC-CM from
the HCE group by the MTT value of MNC-CM untreated
control group.
Preparation of MNC-CM
PHA, a natural mitogen of T lymphocytes, has been used
as an immunostimulant in many studies to simulate
the immune response and effect. To simulate the 
immune reaction for evaluation of drug effects19,20,
PBMNC from human blood, which was stimulated with
PHA at 10 μg/mL, was used as a model system. Articles
on exercise-mediated immunomodulation using the
above model have been published21,22. In this model sys-
tem, various cytokines released from PBMNC by PHA
stimulation have been studied. MNCs were isolated from
the peripheral blood of each subject by Ficoll-Hypaque
solution (1.077 g/mL; Pharmacia Biotech, Uppsala,
Sweden) with density centrifugation (400g for 30 min-
utes)21. MNCs were washed by phosphate-buffered saline
three times and suspended in RPMI 1640 medium
(Sigma-Aldrich, St. Louis, MO, USA) containing 10% heat-
inactivated autoserum, then incubated in autoserum-
coated culture plates. Cells were cultured in 10%
heat-inactivated fetal calf serum (Gibco; Invitrogen) at an
initial concentration of 1×106 cells/mL, with L-glutamine
(Invitrogen) at 1,000 μmol/L, streptomycin (Invitrogen)
at 100 mg/L, penicillin (Invitrogen) at 50 mg/L, and RPMI
1640 medium containing PHA (Sigma-Aldrich) at 10 μg/
mL, at 37°C in a fully humidified incubator with 5%
CO2. The collected aliquot, which had all the MNCs re-
moved by filtering through a 0.45 μm membrane after
cultivation for 24 hours was named the CM, and stored
at –80°C until use23. PHA-MNC-CM was prepared with
PHA at 10 μg/mL for 24 hours to observe the relative
HBsAg expression in Hep3B cells. All of the MNC-CM
were collected to measure the secretion of cytokines.
The MNC-CM included cytokines related to antiviral
and antitumor immunity such as IFN-γ, TNF-α and
interferon alpha (IFN-α). PHA-MNC-CM from the SC
group was termed as SC-PHA-MNC-CM and from the
HCE group as HCE-PHA-MNC-CM.
Assay for cytokines
In the cytokine-neutralizing experimental procedure,
HCE-PHA-MNC-CM were preincubated with various
cytokine-neutralizing antibodies, including anti-IFN-γ
(30.0 μg/mL, which was tenfold more than the concen-
tration at near 100% neutralization), anti-TNF-α (2.4μg/
mL), anti-IFN-α (1.0 μg/mL) and anti-interleukin (IL) 1β
antibodies (5.1μg/mL), alone or in combination at 37°C
for 90 minutes. After 48 hours’ incubation with added
antibodies of the cytokines, all viable cells were mea-
sured. Three separate tests were each performed in
duplicate. The commercial enzyme-linked immunosor-
bent assay (ELISA) kits, which include IFN-γ, IFN-α, TNF-α
and IL-1β (R&D Systems, Minneapolis, MN, USA), were
for measurement at a wavelength of 450 nm to deter-
mine the amount of secreted cytokines in PHA-MNC-CM
Table 1. Anthropometric characteristics of subjects*
HCE group SC group 
(n = 15) (n = 14)
Age (yr) 67.6 ± 5.4 66.3 ± 5.8
Height (cm) 162.5 ± 10.1 162.9 ± 8.2
Weight (kg) 59.4 ± 9.2 62.4 ± 9.1
Body fat (%) 28.5 ± 7.3 30.3 ± 6.4
V· O2peak (mL/kg · min
–1) 25.6 ± 7.1 24.2 ± 6.7
*Data are expressed as mean± standard error of the mean. HCE=habit-
ual cycling exercise; SC=sedentary control; V·O2peak=peak oxygen uptake.
by following the method described by Wang et al23. The
correlation coefficients (r2) for the standard curves of the
above four cytokines were between 0.998 and 0.999.
Assay for relative HBsAg expression
As the presence of HBsAg in serum of HBV virus carri-
ers indicates a current HBV infective status and a risk
of developing compensated cirrhosis and hepatocellu-
lar carcinoma, HBsAg is a common indicator of HBV
activity24–27.
The Hep3B cell line was cultured in Dulbecco’s mod-
ified Eagle’s medium with 10% fetal bovine serum for
24 hours to proliferate to over 1×106 cells/mL, and were
subsequently transferred into serum-free Dulbecco’s
modified Eagle’s medium with or without 30% (vol/
vol) MNC-CM at 1 × 106 cells/mL for 48 hours incuba-
tion. Commercial ELISA kits (General Biological, Taipei,
Taiwan) were used to determine the amount of se-
creted HBsAg in the cultured CM. By preliminary test,
we determined that PHA did not interfere with the
HBsAg assay by the ELISA kits. The measured optical
density values of the ELISA kits during measurement
were normalized to cell numbers. The relative HBsAg
expression was calculated as (HBsAg/MTT) from PHA-
MNC-CM of the HCE group divided by (HBsAg/MTT) from
the untreated control group culture media. The secreted
HBsAg amount per viable Hep3B cell (i.e., HBsAg/MTT)
from the untreated control group culture media was
treated as 100% expression.
Statistical analysis
Results are presented as mean ± standard error of the
mean. Differences between the treatment groups, which
consisted of matched samples, were assessed by the
Student t test. A confidence level of 5% (p < 0.05) was
considered significant.
Results
Anthropometric measurement and 
V· O2peak of subjects
The HCE group had a mean body weight of 59.4 ±
9.2 kg (range, 46–74 kg), mean age of 67.6 ± 5.4 years
(range, 49–78 years), and mean height of 162.5 ± 10.1
(range, 153–176 cm). The SC group had a mean age of
66.3 ± 5.8 years (range, 51–76 years). There were no
differences in the anthropometric measurements be-
tween the SC group and the HCE group (p > 0.05) as
shown in Table 1. The V· O2peak observed in the HCE
group, 25.6 ± 7.1 mL/kg · min–1, was similar to that in
the SC group, 24.2 ± 6.7 mL/kg · min−1 (p > 0.05). From
Table 2, the respiratory exchange ratios before and
after HCE showed no noticeable change. The lactate
concentration in serum (1.68–1.98mmol/L) showed no
marked change. The changes in intensity of HCE were
minor, from the data of percent of V· O2peak (21.26% ±
12.73% to 45.52% ± 13.28%) and percent of maximal
heart rate (49.87%±6.82% to 68.58%±6.71%). The meta-
bolic equivalents were similar before and after HCE.
Comparison of the reduction of relative HBsAg
expression in Hep3B cells stimulated by PHA-
MNC-CM between the SC group and HCE group
After stimulation by PHA, a much greater response
was observed in HCE-PHA-MNC-CM than in SC-PHA-
MNC-CM. There was markedly lower HBsAg expression
of 64.7% in Hep3B cells incubated with HCE-PHA-MNC-
CM in comparison to 81.5% with SC-PHA-MNC-CM
(Table 3). No apparent inhibition of relative HBsAg
expression in Hep3B cells was observed in the SC
group. It should be noted that no obvious Hep3B cell
death was present in either group at a PHA concentra-
tion of 10 μg/mL.
Effects of cytokines on HBsAg expression in
Hep3B cells
PHA-stimulated secretion of all the cytokines, IL-1β,
TNF-α, IFN-γ and IFN-α, in HCE-PHA-MNC-CM markedly
increased to 876 ± 211 pg/mL, 1,293± 289 pg/mL, 712±
125 pg/mL and 1,057 ± 229 pg/mL, respectively, com-
pared with those in SC-PHA-MNC-CM to 312±134pg/mL,
621 ± 251 pg/mL, 387 ± 98 pg/mL and 363 ± 158 pg/mL,
respectively (Table 4).
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Table 2. Blood lactate concentration and energy expenditure
before and after habitual cycling exercise (HCE)*
Before HCE During HCE
Blood lactate (mmol/L) 1.98 ± 0.39 1.68 ± 0.46
%HRmax (%) 49.87 ± 6.82 68.58 ± 6.71
%V· O2peak (%) 21.26 ± 12.73 45.52 ± 13.28
MET 1.3 ± 1.1 4.3 ± 1.3
RER 0.76 ± 0.08 0.75 ± 0.08
*Data are expressed as mean ± standard error of the mean.
%HRmax = percent of maximal heart rate achieved during incremen-
tal exhaustive exercise; %V·O2peak =percent of peak oxygen uptake;
MET = metabolic equivalent; RER = respiratory exchange ratio.
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With the same concentration of PHA (10 μg/mL),
the secreted amounts of TNF-α and IFN-γ in HCE-PHA-
MNC-CM were about twice that in SC-PHA-MNC-CM,
while the secreted amount of IL-1β and IFN-α in HCE-
PHA-MNC-CM was about two times greater than that in
SC-PHA-MNC-CM (Table 4). In order to elucidate the
effects of secreted cytokines on the reduction of relative
HBsAg expression in Hep3B cells, one or more cytokine-
neutralizing antibodies, such as anti-IFN-γ, anti-IFN-α,
anti-IL-1β and anti-TNF-α antibodies, were added to
HCE-PHA-MNC-CM before incubation of Hep3B cells. The
relative HBsAg expression in Hep3B cells decreased to
a lower level of 67.3% ± 12.5% with pretreatment of
anti-IL-1β antibodies in HCE-PHA-MNC-CM; there was
a small, statistically significant increase in relative HBsAg
expression when compared with HCE-PHA-MNC-CM
alone (64.7% ± 12.8%). The relative HBsAg expression
in Hep3B cells increased to 78.7% ± 13.8% in the pres-
ence of anti-IFN-α antibodies, to 82.5% ± 11.7% in the
presence of anti-IFN-γ antibodies, and to 79.3% ±
13.2% in the presence of anti-TNF-α antibodies (Table 3).
With a combination of all three cytokine antibodies,
the greatest effect was seen with the relative HBsAg
expression in Hep3B cells being 87.1% ± 11.4%.
Discussion
The analysis of significant inhibition of HBsAg expres-
sion in an ex vivo experimental model has shown a
greater immunomodulatory response of PBMNC iso-
lated from middle-aged people with HCE than the SCs.
From the basic anthropometric data, the HCE group
and SC group were similar. However, there was a statis-
tically greater V· O2peak in the HCE group than in the SC
group. The percent of maximal heart rate during HCE
at about 68.58% can be defined as moderate exercise.
The other strong evidence to define HCE as moderate
intensity exercise was the fact that %V· O2peak after HCE
was about 45.52% and metabolic equivalent was 4.3.
From the lack of change in blood lactate with exercise
duration, we can refer to the HCE program as aerobic
exercise of low to moderate intensity.
The secreted cytokines, mainly TNF-α, IFN-α and
IFN-γ, dominated the inhibitory effects of HCE-PHA-
MNC-CM. To enhance the response of antiviral immu-
nity, moderate-intensity cycling exercise might be a
possibility. Moderate exercise training could diminish
the activity of influenza virus as shown in another 
in vivo study28. After removal of MNCs, the soluble medi-
ators produced by MNCs in CM rather than the MNC
cells themselves may be the major factors causing
inhibition of HBsAg expression in Hep3B cells.
The much greater amounts of IFN-α, TNF-α and
IFN-γ secreted in HCE-PHA-MNC-CM than in SC-PHA-
MNC-CM indicate a greater response of MNC in the
subjects taking moderate cycling exercise. The neutral-
ization by anti-IFN-γ, anti-TNF-α and/or anti-IFN-α anti-
bodies in HCE-PHA-MNC-CM caused the partial loss of the
inhibitory activity against relative HBsAg expression.
Table 3. Effects of phytohemagglutinin (PHA)-containing
mononuclear cell (MNC) conditioned medium (CM)
and cytokine antibody neutralization on the rela-
tive hepatitis B surface antigen (HBsAg) expression*
Relative HBsAg 
MTT cell 
expression (%)
viability 
assay (%)
Untreated control 100 100
SC-PHA-MNC-CM 81.5 ± 13.7 99.1 ± 12.4
HCE-PHA-MNC-CM† 64.7 ± 12.8 97.5 ± 13.3
+ anti-IL-1β antibodies‡ 67.3 ± 12.5 97.2 ± 11.8
+ anti-IFN-γ antibodies§ 82.5 ± 11.7 99.1 ± 11.4
+ anti-IFN-α antibodies|| 78.7 ± 13.8 97.3 ± 12.8
+ anti-TNF-α antibodies¶ 79.3 ± 13.2 99.1 ± 13.5
+ anti-TNF-α¶ + anti-IFN-α|| + 87.1 ± 11.4 98.2 ± 11.3 
anti-IFN-γ antibodies§
*Triplicated data from separate experiments are expressed as mean ±
standard error of the mean; †aliquots were preincubated, with or
without cytokine-neutralizing antibodies, at 37°C for 90 minutes
before addition to Hep3B cell culture; ‡5.1 μg/mL; §30.0 μg/mL; ||1.0
μg/mL; ¶2.4 μg/mL. MTT = (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide); SC = sedentary control; HCE = habitual cycling
exercise; IL-1b= interleukin 1b; IFN-g= interferon gamma; TFN-
a= interferon alpha; TNF-a= tumor necrosis factor a.
Table 4. Cytokines secreted in phytohemagglutinin (PHA)-
containing mononuclear cell (MNC) conditioned
medium (CM)*
SC-PHA-MNC-CM HCE-PHA-MNC-CM
IL-1β (pg/mL) 312 ± 134 876 ± 211
IFN-α (pg/mL) 363 ± 158 1,057 ± 229
TNF-α (pg/mL) 621 ± 251 1,293 ± 289
IFN-γ (pg/mL) 387 ± 98 712 ± 125
*Triplicated data from separate experiments are expressed as mean ±
standard error of the mean. SC = sedentary control; HCE = habitual
cycling exercise; IL-1b= interleukin 1b; IFN-a= interferon alpha;
TNF-a= tumor necrosis factor a; IFN-g= interferon gamma.
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The results of antibody neutralization showed that sol-
uble factors in CM, including IFN-γ, IFN-α and TNF-α,
may contribute to the greater inhibitory activity against
HBsAg expression in HCE-MNC-CM. It should be noted
that both the MNC and Hep3B cells exhibited no cytotox-
icity (data not shown). Therefore, the greater inhibitory
activity exerted by HCE-MNC-CM in our study came
from the cytokines rather than from the cytotoxicity of
Hep3B cells.
It was reported that active, habitual older runners
with a moderate exercise habit exhibited greater blood
IFN-γ concentration after stimulation by PHA than was
found in sedentary older people9. The effects of IFN-γ
on HBsAg inhibition of patients has also been well doc-
umented in some clinical studies29,30. The obviously
lower relative HBsAg expression after anti-IFN-γ anti-
body neutralization and higher amount of secreted
IFN-γ in HCE-PHA-MNC-CM both provide evidence to
suggest an important inhibitory role played by IFN-γ.
Similar evidence has been presented in other studies,
in which there was a negative correlation between cell
cytoplasmic HBV DNA and the secreted amount of
IFN-γ in the medium of PBMNC31,32.
TNF-α is well known to be an initial activator of
antiviral effects in the immune system. For example,
the administration of TNF-α into the medium led to
suppression of HBV DNA replication in hepatocytes
without cytopathic effects33. An apparent reduction in
HBV replication was observed after addition of TNF-α
to the culture of Hep3B cells34. Both findings regarding
the greater secretion of TNF-α and the lower relative
HBsAg expression with anti-TNF-α antibody neutraliza-
tion in HCE-PHA-MNC-CM in our study indicate that
TNF-α plays a substantial role.
IFN-α has been used in clinical therapy for patients
to inhibit virus replication. IFN-α administered to hep-
atitis B e antigen-positive patients diminished hepatitis
B e antigen in the serum from 40% to 25%35,36. We can
presume that IFN-α exerts important effects on the
inhibition of HBV, because there was a much greater
amount of secreted IFN-α and lower relative HBsAg
expression after the neutralization of anti-IFN-α anti-
body in HCE-PHA-MNC-CM.
In addition, evidence on the antiviral activity of im-
munomodulatory cells activated by increased secretion
of IFN-α in a similar experimental model has been pre-
sented. For instance, the neutralization by specific anti-
body of IFN-α in MNCs reduced the suppressant effects
against herpes simplex viruses37.
Although greater secretion of cytokines was closely
related to the reduction in HBsAg expression, the
Hep3B cells, which are the HBV-harboring host, were
not killed by HCE-PHA-MNC-CM. It can, therefore, be
postulated that the inhibitory activity of HCE-MNC-CM
against HBsAg expression may not be attributed to the
cytotoxicity of Hep3B cells. Both IFN-γ and TNF-α se-
creted from HBV-specific cytotoxic T lymphocytes can
reduce HBV gene expression and replication without
the occurrence of cytopathy25.
After incubation with a combination of anti-TNF-α,
anti-IFN-α and anti-IFN-γ antibodies, the inhibitory
activity against HBsAg expression in HCE-PHA-MNC-CM
was most attenuated. Thus, IFN-γ, IFN-α and TNF-α,
induced by HCE in our study played the crucial immu-
nomodulatory antiviral role.
In conclusion, a greater immunomodulatory re-
sponse against HBsAg expression of a HBV cell line
existed in the HCE group as shown by our ex vivo antivi-
ral immunity model. The much greater secretion of
cytokines, mainly IFN-γ, TNF-α and IFN-α from human
peripheral blood MNC, contributed to the greater im-
munomodulatory response against HBsAg expression
of a HBV cell line by HCE in middle-aged people.
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